| Issue Date | Title | Author(s) |
| 2018-02-01 | The accuracy and precision of Kilovoltage Intrafraction Monitoring (KIM) six degree-of-freedom prostate motion measurements during patient treatments | Kim, JH; Nguyen, DT; Booth, JT; Huang, CY; Fuangrod, T; Poulsen, P; O'Brien, R; Caillet, V; Eade, T; Kneebone, A; Keall, P |
| 2019-12-09 | A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia | Krivtsov, AV; Evans, K; Gadrey, JY; Eschle, BK; Hatton, C; Uckelmann, HJ; Ross, KN; Perner, F; Olsen, SN; Pritchard, T; McDermott, L; Jones, CD; Jing, D; Braytee, A; Chacon, D; Earley, E; McKeever, BM; Claremon, D; Gifford, AJ; Lee, HJ; Teicher, BA; Pimanda, JE; Beck, D; Perry, JA; Smith, MA; McGeehan, GM; Lock, RB; Armstrong, SA |
| 2019-01-01 | In Reply to Dahele and Verbakel | Keall, PJ; Nguyen, DT; O'Brien, R; Zhang, P; Bertholet, J; Poulsen, PR |
| 2014-12-01 | Computational analysis of image-based drug profiling predicts synergistic drug combinations: Applications in triple-negative breast cancer | Brandl, MB; Pasquier, E; Li, F; Beck, D; Zhang, S; Zhao, H; Kavallaris, M; Wong, STC |
| 2018-11-15 | LDHA in neuroblastoma is associated with poor outcome and its depletion decreases neuroblastoma growth independent of aerobic glycolysis | Dorneburg, C; Fischer, M; Barth, TFE; Mueller-Klieser, W; Hero, B; Gecht, J; Carter, DR; de Preter, K; Mayer, B; Christner, L; Speleman, F; Marshall, GM; Debatin, KM; Beltinger, C |
| 2020-10 | Development and External Validation of Radiomics Approach for Nuclear Grading in Clear Cell Renal Cell Carcinoma. | Zhou, H; Mao, H; Dong, D; Fang, M; Gu, D; Liu, X; Xu, M; Yang, S; Zou, J; Yin, R; Zheng, H; Tian, J; Pan, C; Fang, X |
| 2020-12 | Non-coding RNAs underlying chemoresistance in gastric cancer. | Poursheikhani, A; Bahmanpour, Z; Razmara, E; Mashouri, L; Taheri, M; Morshedi Rad, D; Yousefi, H; Bitaraf, A; Babashah, S |
| 2020-07 | Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial. | Keall, P; Nguyen, DT; O'Brien, R; Hewson, E; Ball, H; Poulsen, P; Booth, J; Greer, P; Hunter, P; Wilton, L; Bromley, R; Kipritidis, J; Eade, T; Kneebone, A; Hruby, G; Moodie, T; Hayden, A; Turner, S; Arumugam, S; Sidhom, M; Hardcastle, N; Siva, S; Tai, K-H; Gebski, V; Martin, J |
| 2013-05-23 | Functional characterization of cancer-associated Gab1 mutations. | Ortiz-Padilla, C; Gallego-Ortega, D; Browne, BC; Hochgräfe, F; Caldon, CE; Lyons, RJ; Croucher, DR; Rickwood, D; Ormandy, CJ; Brummer, T; Daly, RJ |
| 2013-09 | BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer. | Stone, A; Cowley, MJ; Valdes-Mora, F; McCloy, RA; Sergio, CM; Gallego-Ortega, D; Caldon, CE; Ormandy, CJ; Biankin, AV; Gee, JMW; Nicholson, RI; Print, CG; Clark, SJ; Musgrove, EA |
